Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis
Francesca Ceccherini-Silberstein,
Joseph Fokam,
Vittorio Colizzi,
Desire Takou,
Carlo-Federico Perno,
Georgia Ambada,
Maria-Mercedes Santoro,
Sharon R Lewin,
Aude Christelle Ka’e,
Aubin Nanfack,
Bouba Yagai,
Bertrand Sagnia,
Alex Durand Nka,
Ezechiel Ngoufack Jagni Semengue,
Willy Pabo,
Nelson Sonela,
Caroline T Tiemessen
Affiliations
Francesca Ceccherini-Silberstein
Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
Joseph Fokam
Laboratory of Virology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Vittorio Colizzi
Faculty of Sciences & Technology, Evangelic University of Cameroon, Bandjoun, Cameroon
Desire Takou
Laboratory of Virology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Carlo-Federico Perno
Bambino Gesu Pediatric Hospital, Rome, Italy
Georgia Ambada
Laboratory of Immunology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Maria-Mercedes Santoro
Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
Sharon R Lewin
The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
Aude Christelle Ka’e
Laboratory of Virology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Aubin Nanfack
Laboratory of Immunology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Bouba Yagai
Central Technical Group, National AIDS Control Committee (NACC), Yaounde, Cameroon
Bertrand Sagnia
Laboratory of Immunology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Alex Durand Nka
Laboratory of Virology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Ezechiel Ngoufack Jagni Semengue
Laboratory of Virology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Willy Pabo
Faculty of Sciences, University of Buea, Buea, Cameroon
Nelson Sonela
Laboratory of Immunology, Chantal Biya International Reference Centre for HIV/AIDS Research on Prevention and Treatment, Yaounde, Cameroon, Yaounde, Cameroon
Caroline T Tiemessen
Cell Biology laboratory, National Institute for Communicable Diseases, University of the Witwatersrand, Johannesburg, South Africa
Introduction The success of antiretroviral therapy (ART) has changed HIV from a deadly to a chronic infection, thus increasing the transitioning from infancy toward adulthood. However, the virostatic nature of antiretrovirals maintains viruses in sanctuaries, with reactivation potentials. Because current ARTs are very limited for children, the emergence of new HIV epidemics driven by HIV drug-resistance mutations is favoured. Our systematic review aims to estimate the global burden of archived drug-resistance mutations (ADRMs) and the size of reservoir (HIV-1 DNA load), and their associated factors in children and adolescents.Methods and analysis Papers from the PubMed/MEDLINE, Google Scholar, ScienceDirect, African Journals Online and Academic Medical Education Databases will be systematically identified using the keywords: “HIV-1 reservoirs”, “viral reservoirs”, “HIV-1 DNA”, infants, adolescents, child and children, linked by the following Boolean operators: ‘OR’ and ‘AND’. Randomised and non-randomised trials, cohort studies and cross-sectional studies published in French or English from January 2002 will be included, while case reports, letters, comments, reviews, systematic reviews and meta-analyses, and editorials will be excluded. All studies describing data on ADRMs, HIV-1 DNA load and/or immunological markers among children/adolescents will be eligible. A random-effects model will be used to calculate the pooled prevalence of ADRMs. Data will be reported according to type of viral reservoir (peripheral blood mononuclear cells, CD4 cells), geographical location (country/continent), ethnicity/race, age (infants vs adolescents), gender, HIV-1 clades, ART exposure (naïve vs treated, drug class, type of regimen, age at ART initiation and treatment duration), WHO clinical staging (I, II, III, IV), immune status (immune compromised vs immune competent) and virological response (viraemic vs non-viraemic). Multivariate logistic regression will be performed to determine predictors of HIV reservoir profile in paediatric populations. The primary outcome will be to assess the genotypical and quantitative profile of HIV reservoirs, while the secondary outcomes will be to identify factors associated with ADRMs and reservoir size in paediatric populations.Ethics and dissemination Ethical approval is not applicable for this study as it will be based on published data. Results will be disseminated via a peer-reviewed scientific journal and relevant conferences.PROSPERO registration number CRD42022327625.